9 completed. 9 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 9 |
Follow Ventolin: new trials by email Literature Review of Ventolin trials Research Report on Ventolin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma. CMAB007, Symbicort, Seretide - Asthma, Allergic | Phase 3 | Completed | Shanghai Biomabs Pharmaceutical Co., Ltd. | 393 | 2018-05-09 | 2021-10-11 |
| Adding Nebulized Salbutamol to Intravenous Atropine and Oxygen in OP Poisoning Standard care, Standard care+ 2.5 mg Salbutamol, Standard care+ 5 mg Salbutamol - Organophosphate Poisoning | Phase 3 | Completed | Sylhet M.A.G.Osmani Medical College | 75 | 2015-04-01 | 2015-12-29 |
| Study on Foster Efficacy Maintenance and Reliever vs Foster Maintenance + Salbutamol Reliever in Asthmatics (MART2) Salbutamol, Beclomethasone dipropionate + Formoterol - Asthma | Phase 3 | Completed | Chiesi Farmaceutici S.p.A. | 1714 | 2009-03-20 | 2026-05-07 |
| Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED) Placebo, SCH 697243, Loratadine 10 mg Rescue Treatment - Rhinoconjunctivitis, Rhinitis | Phase 3 | Completed | ALK-Abelló A/S | 439 | 2007-11-01 | 2017-03-03 |
| Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) Placebo, SCH 697243, Loratadine Syrup 1 mg/mL Rescue Treatment - Rhinoconjunctivitis, Rhinitis | Phase 3 | Completed | ALK-Abelló A/S | 345 | 2007-11-01 | 2017-03-03 |
| Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room. Budesonide, albuterol, Ipratropium bromide - Asthma | Phase 3 | Completed | Northwell Health | 95 | 2007-09-01 | 2016-01-21 |
| Symbicort Onset of Action 1 budesonide/formoterol (Symbicort), fluticasone/salmeterol (Advair Diskus), albuterol (Ventolin) - Asthma | Phase 3 | Completed | AstraZeneca | 48 | 2003-04-01 | 2009-04-06 |
| Symbicort Onset of Action 2 budesonide/formoterol, fluticasone/salmeterol, albuterol - Asthma | Phase 3 | Completed | AstraZeneca | 48 | 2003-03-01 | 2011-01-24 |
| Study of Levalbuterol and Racemic Albuterol in Pediatric Subjects With Reactive Airways Disease (RAD) Levalbuterol HCl Inhalation Solution, Albuterol HCl Inhalation Solution - Reactive Airways Disease (RAD) | Phase 3 | Completed | Sumitomo Pharma America, Inc. | 117 | 2001-02-01 | 2012-02-22 |
Asthma (5) · Conjunctivitis (2) · Hypersensitivity (2) · Rhinitis (2) · Emergencies (1) · Organophosphate Poisoning (1) · Pulmonary Disease, Chronic Obstructive (1)
ALK-Abelló A/S (2) · AstraZeneca (2) · Chiesi Farmaceutici S.p.A. (1) · Northwell Health (1) · Shanghai Biomabs Pharmaceutical Co., Ltd. (1) · Sumitomo Pharma America, Inc. (1) · Sylhet M.A.G.Osmani Medical College (1)
United States (2) · Bangladesh (1) · Bulgaria (1) · Canada (1) · China (1) · Croatia (1) · Czechia (1) · France (1) · Germany (1) · Italy (1) · Poland (1) · Romania (1) · Russia (1) · Serbia (1) · Spain (1)
Catherine Bonuccelli (2) · Alberto Papi, Professor (1) · Fazle R Chowdhury, FCPS (1) · Michael Eddleston, PhD (1) · Nanshan Zhong, M.D. (1) · Robert Silverman, MD (1)
PMID 25685162, PMID 21211642, PMID 21211643, PMID 24321801, PMID 31695864, PMID 41345745
2008 (1)